本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

0.6861
-0.0841-10.92%
盤前0.71540.0186+2.67%08:59 EDT
成交量:8.92萬
成交額:6.25萬
市值:57.55萬
市盈率:-0.01
高:0.7400
開:0.7400
低:0.6792
收:0.7702
52周最高:19.40
52周最低:0.6792
股本:83.88萬
流通股本:82.75萬
量比:1.05
換手率:10.77%
股息:- -
股息率:- -
每股收益(TTM):-53.5009
每股收益(LYR):-144.8126
淨資產收益率:-61.77%
總資產收益率:-39.04%
市淨率:0.04
市盈率(LYR):0.00

資料載入中...

2025/12/11

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/08

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/09/30

SEC問詢函

Form CORRESP - Correspondence
2025/08/20

SEC問詢函

Form CORRESP - Correspondence
2025/04/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC問詢函

Form CORRESP - Correspondence
2025/01/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/12

SEC問詢函

Form CORRESP - Correspondence
2024/06/06

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/21

SEC問詢函

Form CORRESP - Correspondence